In recent months, a link has been observed between coronavirus vaccines that rely on messenger RNA technology (mRNA) and some heart infections, but a new study considered that this constitutes “very rare cases,” according to the “Times of Israel” website.
An Israeli study conducted by Clalit, Israel’s largest healthcare provider, with Beilinson Medical Center, concluded that the risk of developing myocarditis and inflammation of the lining surrounding the heart is “very small.”
The study relied on data on 2.5 million Israelis who had been vaccinated, and 94 percent of them received two doses of the vaccine.
It found that this type of infection occurred in 54 people (51 men and three women), or an average of 2.13 out of every 100,000 people who received the vaccine. Of these, 98 percent of cases were mild, 76 percent were moderate, and 22 percent were without any damage to heart function.
The study found that one in 2.5 million people had a serious condition that required hospitalization, and then recovered.
And monitor heart inflammation in younger males, after the second dose, as the study proved that 69 percent of the cases were infected after the second dose, and most of them were in males and in the age group 16-29 years.
In turn, a researcher at the Beilinson Center, Ran Kornovsky, confirmed that this case is “relatively rare,” describing the results of the study as “important.”
At the beginning of October, health officials in Canada said that there was data indicating that the rare cases of heart infection were relatively more, in people vaccinated with the Moderna vaccine against Corona, compared to people vaccinated with Pfizer Biontech vaccines.
A Public Health Agency of Canada statement said that the majority of those infected had relatively mild symptoms and recovered quickly.
The statement added that it was found that the risk of heart complications, including inflammation of the heart, increased significantly after infection with corona.
In contrast, regulators in the United States, the European Union and the World Health Organization stress that the benefits of vaccination to prevent corona still outweigh the risks.
About 37 percent of Israel’s population of 9.4 million received a third booster dose. The number of Covid-19 patients who were transferred to hospitals in serious cases has decreased in the past days, and the number of confirmed daily infections has decreased to less than four thousand after exceeding ten thousand, last September.